Skip to content

Use of Infrared Spectroscopy in Fast Septic Arthritis Diagnosis

Use of Infrared Spectroscopy in Fast Septic Arthritis Diagnosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04004962
Acronym
SYNOFRESH
Enrollment
360
Registered
2019-07-02
Start date
2019-09-16
Completion date
2021-05-08
Last updated
2021-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Effusion

Brief summary

To study the diagnostic performance of infrared spectroscopy on fresh synovial fluids in early septic arthritis diagnosis in patients with acute joint effusion

Detailed description

Diagnosis of a joint effusion is frequently a medical emergency, especially when septic arthritis is suspected. Septic arthritis diagnosis relies on microscopic and bacteriological analysis of synovial fluid obtained by arthrocentesis. Direct microscopic examination can be made within 2 to 12 hours but it is negative in about 50 % of the cases. It is necessary to wait 72 hours to obtain the result of the culture and reasonably rule out the diagnosis of septic arthritis. A method of establishing an immediate etiological diagnosis could improve the care of patients with joint effusion that is a therapeutic emergency and justify a hospitalization and a parenteral antibiotic therapy.

Interventions

Infrared spectroscopy

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients over 18 year old * patients with an acute arthritis defined by an evolution of less than 6 weeks * patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study * patients who received information about the protocol and have not expressed opposition to participate

Exclusion criteria

* patients opposing the study * protected major (safeguard justice, trusteeship and guardianship) and persons deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of the cause of joint effusionUp to 7 days (time to perform Spectroscopy and collect laboratory results)The final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis

Secondary

MeasureTime frameDescription
Number of days of hospitalizationUp to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)The clinician will be asked to state how a positive or a negative result of the diagnostic test under study would have affected his decision to hospitalize the patient
Total dose of antibioticsUp to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)The clinician will be asked to state how a positive or a negative result of the diagnostic test under study would have affected his decision to start antibiotic therapy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026